Patent ID: 9034821
Filing Date: 2015-05-19
Classification: A61K,A61P

Abstract:
1. A composition comprising a. oxytocin (SEQ ID NO:1), and/or one or more fragment(s) and/or variant(s) thereof according to SEQ ID NO:2, as well as pharmaceutically acceptable salts thereof; and b. at least one non-ionic cellulose ether; wherein SEQ ID NO:2 is X 1 —X 2 —X 3 —X 4 -Asn-Cys-X 5 —X 6 —X 7 —X 8 —NH 2 wherein X 1 is selected from the group consisting of Cys and nothing; X 2 is selected from the group consisting of Tyr, Phe, and nothing; X 3 is selected from the group consisting of Ile, Val, Hoph, Phe, Cha, and nothing; X 4 is selected from the group consisting of Gln, Ser, Thr, Cit, Arg, and Daba; X 5 is selected from the group consisting of Pro and nothing; X 6 is selected from the group consisting of Ile, Leu, nothing, Val, Hos, Daba, Thr, Arg, and Cit; X 7 is selected from the group consisting of Gly, nothing, and Ala; X 8 is selected from the group consisting of Gly and nothing; further provided that SEQ ID NO: 2 is not SEQ ID NO:7; wherein said composition has a pH within the range of between 3 and 4.